Sarepta Therapeutics Inc (NASDAQ:SRPT)

84.49
Delayed Data
As of Dec 01
 +3.21 / +3.95%
Today’s Change
55.25
Today|||52-Week Range
159.89
-34.80%
Year-to-Date

Stock Price Forecast

The 18 analysts offering 12-month price forecasts for Sarepta Therapeutics Inc have a median target of 140.00, with a high estimate of 224.00 and a low estimate of 80.00. The median estimate represents a +65.70% increase from the last price of 84.49.

Analyst Recommendations

The current consensus among 20 polled investment analysts is to Buy stock in Sarepta Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$1.24
Sales
$328.6M
Reporting Date
Feb 27

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -168.74%
 
 
 
 
 
 
Growthannually -26.56%
 
 
 
 
 
 

Sales

Growthquarterly -0.97%
 
 
 
 
 
 
Growthannually 21.61%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.